1. bookTom 24 (2011): Zeszyt 6 (November 2011)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2719-9509
Pierwsze wydanie
01 Jan 1992
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Otwarty dostęp

Problems with the Tobacco Products Scientific Advisory Committee (TPSAC) List of Harmful or Potentially Harmful Tobacco and/or Tobacco Smoke Components

Data publikacji: 30 Dec 2014
Tom & Zeszyt: Tom 24 (2011) - Zeszyt 6 (November 2011)
Zakres stron: 258 - 276
Otrzymano: 28 Oct 2010
Przyjęty: 06 Jun 2011
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2719-9509
Pierwsze wydanie
01 Jan 1992
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. International Agency for Research on Cancer (IARC): Evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking; IARC, Lyon, France, IARC Monograph 38 (1986).Search in Google Scholar

2. Hoffmann, D. and E. L. Wynder: Chemical constituents and bioactivity of tobacco smoke; in: Tobacco: A major health hazard, edited by D. G. Zardidze and R. Peto, IARC, Lyon, France, IARC Sci. Publ. No. 74 (1986) 145-165.Search in Google Scholar

3. Hoffmann, D. and S. S. Hecht: Advances in tobacco carcinogenesis; in: Chemical carcinogenesis and muta-genesis, edited by C. S. Cooper and P. Grover, Springer-Verlag, London, UK (1990) 64–102.Search in Google Scholar

4. Hoffmann, D., A. Rivenson, F. L. Chung, and E. L. Wyn-der: Potential inhibitors of tobacco carcinogenesis; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks, edited by J. N. Diana and W. A. Pryor, Ann. N. Y. Acad. Sci. 686 (1993) 140–160.Search in Google Scholar

5. Hoffmann, D. and I. Hoffmann: [Chemical studies on tobacco smoke. C.] The changing cigarette: 1950–1995; J. Toxicol. Environ. Hlth. 50 (1997) 307–364.Search in Google Scholar

6. Hoffmann, D. and I. Hoffmann: Tobacco smoke compo-nents. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 49–52.Search in Google Scholar

7. Hoffmann, D. and I. Hoffmann: The changing cigarette: Chemical studies and bioassays; Chapter 5 in: Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, NCI Smoking and Tobacco Control, Monograph 13, edited by D. M. Burns and N. L. Benowitz, Bethesda, MD, (2001) 159–191.Search in Google Scholar

8. Hoffmann, D., I. Hoffmann, and K. El-Bayoumy: The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder; Chem. Res. Toxicol. 14 (2001) 767–790.Search in Google Scholar

9. Fowles, J. and M. Bates: The chemical constituents in cigarettes and cigarette smoke: Priorities for harm reduction; A Report to the New Zealand Ministry of Health, March 2000, pp. 1–65, see www.ndp. govt. nz/ tobacco/documents/tobaccochem. pdf. *Search in Google Scholar

10. Occupational Safety and Health Administration (OSHA): Indoor air quality; Fed. Reg. 59 (No. 65) (1994) 15968–16039.Search in Google Scholar

11. Closing Quotes Department: Dietrich Hoffmann: Author of the list; Tobacco Reporter (July 2002) 70–72.Search in Google Scholar

12. Rodgman, A.: The composition of cigarette smoke: Problems with lists of tumorigens; Beitr. Tabakforsch. Int. 20 (2003) 402–437.Search in Google Scholar

13. Rodgman, A. and C. R. Green: Toxic chemicals in cigarette mainstream smoke-hazard and hoopla; in: Cigarette risk and the potential for risk reduction; Proc. of the 2002 CORESTA Congress, New Orleans, LA, pp. 2-52, see www.rjrtdocs. com 526909637–9687; Beitr. Tabakforsch. Int. 20 (2003) 481–545.Search in Google Scholar

13a. Tobacco Products Scientific Advisory Committee (TPSAC): Draft initial list of harmful/potentially harmful constituents in tobacco smoke or smokeless tobacco products; August 2010.Search in Google Scholar

14. Shear, M. J. and J. Leiter: Studies in carcinogenesis. XVI. Production of subcutaneous tumors in mice by miscellaneous polycyclic compounds; J. Natl. Cancer Inst. 2 (1941) 241–258.Search in Google Scholar

15. Fay, J. R., L. R. Perry, L. A. Kanerva, C. C. Sigman, and C. T. Helmes: Inhibitors of chemical carcinogenesis; Document prepared in 1984, revised in 1985 for the Office of the Scientific Coordinator for Environmental Cancer, NCI, Bethesda, MD (1985) 1–96.Search in Google Scholar

16. Kennaway, E. L. and I. Hieger: Carcinogenic substances and their fluorescent spectra; Brit. Med. J. 1 (1930) 1044–1046.Search in Google Scholar

17. Cook, J. W., C. L. Hewitt, and I. Hieger: Isolation of a cancer-producing hydrocarbon from coal tar. II. Isolation of 1,2- and 4,5-benzpyrenes, perylene, and 1,2-benzanthracene; J. Chem. Soc. (1933) 395–398; Barry, G., J. W. Cook, G. A. D. Haslewood, C. L. Hewett, I. Hieger, and E. L. Kennaway: The production of cancer by pure hydrocarbons. Part III; Proc. Royal Soc. (Biol.) 117 (1935) 318–351.Search in Google Scholar

18. Hartwell, J. L.: Survey of compounds which have been tested for carcinogenic activity; USPHS Publ. No. 149, 2nd Edition, Washington, DC (1951).Search in Google Scholar

19. Shubik, P. and J. L. Hartwell: Survey of compounds which have been tested for carcinogenic activity, Suppl. 1; USPHS Publ. No. 149, Washington, DC (1957).Search in Google Scholar

20. Dipple, A.: Polynuclear aromatic hydrocarbons; in: Chemical carcinogens, 1st edition, edited by C. E. Searle, American Chemical Society Monograph 173 (1976) 245–314.Search in Google Scholar

21. Steiner, P. E. and H. L. Falk: Summation and inhibition effects of weak and strong carcinogenic hydrocarbons, 1:2-benzanthracene, chrysene, 1:2:5:6-dibenzanthracene, and 20-methylcholanthrene; Cancer Res. 11 (1951) 56–63.Search in Google Scholar

22. Hill, W. T., D. W. Stanger, A. Pizzo, B. Riegel, P. Shubik, and W. B. Wartman: Inhibition of 9,10-dimethyl-1,2-benzanthracene skin carcinogenesis in mice by poly-cyclic hydrocarbons; Cancer Res. 11 (1951) 892–897.Search in Google Scholar

23. Wynder, E. L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Aca-demic Press, New York, NY (1967).Search in Google Scholar

24. Crabtree, H. G.: Some effects of aromatic hydrocarbons on sulfur metabolism and tumor induction in mice; Cancer Res. 6 (1946) 553–559; Anticarcinogenesis; Brit. Med. Bull. 4 (1947) 345; Influence of bromobenzene on the induction of skin tumors by 3,4-benzopyrene; Cancer Res. 4 (1944) 688–693; Influence of unsaturated dibasic acids on the induction of skin tumors by chemical carcinogens; Cancer Res. 5 (1945) 346–351.Search in Google Scholar

25. Wynder, E. L. and D. Hoffmann: Studies with the gas-eous and particulate phase of tobacco smoke; Proc. Am. Assoc. Cancer Res. 3(4) (1962) 373.Search in Google Scholar

26. Kallistratos, G.: Verhinderung der 3,4-Benzopyren-kanzerogenese durch natürliche und synthetische Verbindungen [Inhibition of 3,4-benzopyrene carcino-genesis by natural and synthetic compounds]; Münch. Med. Wochenschr. 117 (1975) 391–394.Search in Google Scholar

27. Kallistratos, G. and E. Fasske: Biologische inactivierung kanzerogener Stoffe [Biological inactivation of carcino-genic substances]; Folia Biochem. Biol. Graeca 13 (1976) 94–107.Search in Google Scholar

28. Wattenberg, L. W., J. B. Coccia, and K. T. Lam: Inhibitory effects of phenolic compounds on benzo[a]pyrene-induced neoplasia; Cancer Res. 40 (1980) 2820–2823.Search in Google Scholar

29. Wattenberg, L. W.: Inhibitors of chemical carcinogens; in: Cancer: Achievements, challenges and prospects for the 1980’s, edited by J. H. Burchenal, Grune and Stratton, New York, NY (1981) 517–539.Search in Google Scholar

30. Wattenberg, L. W., L. K. T. Lam, and A. V. Fladmoe: Inhibition of chemical carcinogen-induced neoplasia by coumarins and -angelica lactone; Cancer Res. 39 (1979) 1651–1654.Search in Google Scholar

31. Berry, D. L., T. J. Slaga, J. DiGiovanni, and M. R. Juchau: Chlorinated dibenzo-p-dioxins, polybrominated biphen-yls, and polychlorinated biphenyls in a two-stage system of mouse skin tumorigenesis: Potent anticarcinogenic effects; Ann. NY Acad. Sci. 320 (1979) 405–414.Search in Google Scholar

32. Cohen, G. M., W. P. Bracken, R. P. Iyer, D. L. Berry, and T. J. Slaga: Anticarcinogenic effects of 2,3,7,8-tetra-chlorodibenzo-p-dioxin on benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene tumor initiation and its relationship to DNA binding; Cancer Res. 39 (1979) 4027–4033.Search in Google Scholar

33. DiGiovanni, J., D. L. Berry, G. L. Gleason, G. S. Kishore, and T. J. Slaga: Time-dependent inhibition by 2,3,7,8-tetrachlorodibenzo-p-dioxin of skin tumorigenesis with polycyclic hydrocarbons; Cancer Res. 40 (1980) 1580–1587.Search in Google Scholar

34. Van Duuren, B. L., A. Sivak, C. Katz, and S. Mel-chionne: Cigarette smoke carcinogenesis: Importance of tumor promoters; J. Natl. Cancer Inst. 47 (1971) 235–240.Search in Google Scholar

36. Lesca, P.: Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice; Carcinogenesis 4 (1983) 1651–1653.Search in Google Scholar

37. Wattenberg, L. W. and W. D. Loub: Inhibition of poly-cyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles; Cancer Res. 38 (1978) 1410–1412.Search in Google Scholar

38. Sunderman, F. W., K. S. McCully, S. B. Taubman, P. R. Allpass, M. C. Reid, and L. A. Rinehimer: Manganese inhibition of sarcoma induction by benzo[a]pyrene in rats; Carcinogenesis 1 (1980) 613–620.Search in Google Scholar

39. Lam, L. K. T., R. P. Pai, and L. W. Wattenberg: Synthesis and chemical carcinogen inhibitory action of 2-tert-butyl-4-hydroxyanisole; J. Med. Chem. 22 (1979) 569–571.Search in Google Scholar

40. Slaga, T. J. and W. M. Bracken: The effect of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxy-lase; Cancer Res. 37 (1977) 1631–1635.Search in Google Scholar

41. Slaga, T. J., V. I. Solanki, and M. Logani: Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion; in: Radioprotectors and anticarcinogens, edited by O. F. Ngaard and M. G. Simic, Academic Press, New York, NY (1983) 471–485.Search in Google Scholar

42. Wattenberg, L. W.: Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxi-dants and ethoxyquin; J. Natl. Cancer Inst. 48 (1972) 1425–1430.Search in Google Scholar

43. International Agency for Research on Cancer (IARC): Chrysene; in: Evaluation of the carcinogenic risk of chemicals to humans: Polynuclear aromatic hydrocarbons. Part 1. Chemical, environmental and experimental data; IARC, Lyon, France, IARC Monograph 32 (1983) 247–261.Search in Google Scholar

44. DiGiovanni, J., T. J. Slaga, D. L. Berry, and M. R. Juchau: Inhibitory effects of environmental chemicals on poly-cyclic aromatic hydrocarbon carcinogenesis; in: Carcino-genesis. A comprehensive survey. Vol. 5, edited by T. J. Slaga, Raven Press, New York, NY (1980) 145–168.Search in Google Scholar

45. Slaga, T. J., L. Jecker, W. M. Bracken, and C. E. Weeks: The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene; Cancer Lett. 7 (1979) 51–59.Search in Google Scholar

46. Homburger, F., A. Treger, and E. Boger: Inhibition of murine subcutaneous and intravenous benzopentaphene carcinogenesis by sweet orange oils and d-limonene; Oncology 25 (1971) 1–10.Search in Google Scholar

47. Mathews-Roth, M. M.: Antitumor activity of b-carotene, canthaxanthin, and phytoene; Oncology 39 (1982) 33–37.Search in Google Scholar

48. Slaga, T. J. and R. K. Boutwell: Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethyl-benz[a]anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene; Cancer Res. 37 (1977) 129–133.Search in Google Scholar

49. Slaga, T. J., A. Viaje, S. G. Buty, and W. M. Bracken: Dibenz[a, c]anthracene: A potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene; Res. Comm. Chem. Pathol. Pharmacol. 19 (1978) 477–483.Search in Google Scholar

50. Saito, Y., H. Takizawa, S. Konishi, D. Yoshida, and S. Mizusaki: Identification of cembratriene-4,6-diol as an antitumor-promoting agent from cigarette smoke conden-sate; Carcinogenesis 6 (1985) 1189–1194.Search in Google Scholar

51. Shamberger, R. J.: Inhibitory effect of vitamin A on carcinogenesis; J. Natl. Cancer Inst. 47 (1971) 667–673.Search in Google Scholar

51. Perchellet, J. -P. and R. K. Boutwell: Effects of 3-iso-butyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate; Cancer Res. 41 (1981) 3927–3935.Search in Google Scholar

52. Wattenberg, L. W.: Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds; J. Natl. Cancer Inst. 58 (1977) 395–398.Search in Google Scholar

53. Wattenberg, L. W.: Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate subsequent to carcinogen expo-sure; Cancer Res. 41 (1981) 2991–2994.Search in Google Scholar

54. Klein, M.: Inhibition of skin tumorigenesis in Strain B6AF1/J female mice with maleic anhydride; J. Natl. Cancer Inst. 34 (1965) 175–183.Search in Google Scholar

55. Shamberger, R. J.: Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis; J. Natl. Cancer Inst. 44 (1970) 931–936.Search in Google Scholar

56. Yasukawa, K., M. Takido, T. Matsumoto, M. Takeuchi, and S. Nakagawa: Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter and sito-sterol and betulic acid inhibit tumor formation in mouse skin two-stage carcinogenesis; Oncology 48 (1991) 72–76.Search in Google Scholar

57. Shklar, G.: Oral mucosa carcinogenesis in hamsters. Inhibition by vitamin E; J. Natl. Cancer Inst. 68 (1982) 791–797.Search in Google Scholar

58. Viaje, A., T. J. Siege, M. Wigler, and I. B. Weinstein: Effects of anti-inflammatory agents in mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator; Cancer Res. 37 (1977) 1530–1536.Search in Google Scholar

59. Weerapradist, W. and G. Shklar: Vitamin E inhibition of hamster buccal pouch carcinogenesis; Oral Surg. 54 (1982) 304–312.Search in Google Scholar

60. Van Duuren, B. L., J. A. Bilbao, and C. A. Joseph: The origin and nature of the nitrogen heterocyclics in ciga-rette smoke condensate; Proc. Am. Chem. Soc. Mtg. -In-Miniature, New York, NY (1960); The carcinogenic nitrogen heterocycles in cigarette smoke condensate; J. Natl. Cancer Inst. 25 (1960) 53–61.Search in Google Scholar

61. Rodgman, A.: Tobacco smoke components. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 127–129.Search in Google Scholar

62. Baker, R. R.: Smoke chemistry; Chapter 12 in: Tobacco: Production, chemistry and technology, edited by D. L. Davis and M. T. Nielsen, Blackwell Science, Oxford, UK (1999) 398–439.Search in Google Scholar

63. Rodgman, A.: A comparison of the chemical, physical, and biological properties of cigarette mainstream smoke (MS), cigarette sidestream smoke (SS), and environmen-tal tobacco smoke (ETS); Report submitted to the U. S. Environmental Protection Agency (December 1991; revised July 1992), pp. i–vii + 1–117, see www.rjrt docs. com 512527469–7599, 521184527–4657, 521187004–7125.Search in Google Scholar

64. Candeli, A., D. Hoffmann, and E. L. Wynder: Unpub-lished 1963 data cited in E. L. Wynder and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249–453, see 323–333; also cited in: E. L. Wynder and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press, New York, NY (1967), see pp. 373–374, Table VIII-14.Search in Google Scholar

65. Wynder, E. L. and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249–453.10.1016/S0065-230X(08)60510-2Search in Google Scholar

66. Kaburaki, Y., S. Sugawara, U. Kobashi, and T. Doihara: Studies on the composition of tobacco smoke. XIV. The formation of pyridines in the pyrolysis of nicotine; J. Agr. Chem. Soc. Japan 44 (1970) 224–231.Search in Google Scholar

67. Schmeltz, I., W. S. Schlotzhauer, and E. B. Higman: Characteristic products from pyrolysis of nitrogenous or-ganic substances; Beitr. Tabakforsch. 6 (1972) 134–138.Search in Google Scholar

68. Schmeltz, I., A. Wenger, D. Hoffmann, and T. C. Tso: Use of radioactive tracers to determine cigarette smoke components that arise from nicotine during combustion; 31st Tobacco Chemists’ Research Conference, Program Booklet and Abstracts, Vol. 31, Paper No. 17, 1977, p. 9; Chemical studies on tobacco smoke. 63. On the fate of nicotine during pyrolysis and in a burning cigarette; J. Agr. Food Chem. 27 (1979) 602–608.Search in Google Scholar

69. Snook, M. E.: Gel elution of heterocyclic analogues of polynuclear aromatic hydrocarbons from bio-beads; Anal. Chim. Acta 99 (1978) 299–304.Search in Google Scholar

70. Snook, M. E., P. J. Fortson, L. B. Smith, and O. T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; 32nd Tobacco Chemists’ Research Confer-ence, Program Booklet and Abstracts, Vol. 32, Paper No. 46, 1978, p. 25; Snook, M. E., P. J. Fortson, and O. T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; Beitr. Tabakforsch. Int. 11 (1981) 67–78.Search in Google Scholar

70a. Grimmer, G., K. W. Naujack, and G. Dettbarn: Gas chro-matographic determination of polycyclic aromatic hydro-carbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes; Int. Exptl. Symp. on Passive Smoking, Essen, Germany; Gas chromatographic determination of polycy-clic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigaretttes; Toxicol. Lett. 35 (1987) 117–124.Search in Google Scholar

71. Kamata, K., N. Motohashi, R. Meyer, and Y. Yama-moto: Analysis of benz[c]acridines in cigarette smoke by high-performance liquid chromatography; J. Liq. Chromatog. 15 (1992) 1907–1920.Search in Google Scholar

72. Sasaki, T. A. and S. C. Moldoveanu: Analysis of dibenz [a, j]acridine in particulate-phase cigarette smoke; 53rd Tobacco Science Research Conference, Program Booklet and Abstracts, Vol. 53, Paper No. 32, 1999. p. 37; Determination of dibenz[a, j]acridine in the particulate phase of cigarette smoke; Beitr. Tabakforsch. Int. 19 (2000) 25–31.Search in Google Scholar

73. Rustemeier, K., R. Stabbert, H. J. Haussmann, E. Roemer, and E. L. Carrnines: Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke; Food Chem. Toxicol. 40 (2002) 93–104.Search in Google Scholar

74. Schüller, H. M., A. Castonguay, M. Orloff, and G. Rossignol: Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine; Cancer Res. 51 (1991) 2009–2114.Search in Google Scholar

75. Lee, C. K., C. W. Fulp, D. W. Bombick, and D. J. Doo-little: Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents; Mutation Res. 367 (1996) 83–92.Search in Google Scholar

76. Lee, C. K., J. A. Munoz, C. W. Fulp, K. -M. Chang, J. C. Rogers, M. F. Borgerding, and D. J. Doolittle: Inhibitory activity of cigarette-smoke condensate on the mutageni-city of heterocyclic amines; Mutation Res. 322 (1994) 21–32.Search in Google Scholar

77. Cohen, B. I., R. F. Raicht, and E. Fazzini: Reduction of N-methyl-N-nitrosourea-induced colon tumors in the rat by cholesterol; Cancer Res. 42 (1982) 5050–5052.Search in Google Scholar

78. Takeda, K., S. Ukawa, and M. Mochizuki: Inhibition by fatty acids of direct mutagenicity of N-nitroso com-pounds; in: Relevance to human cancer of N-nitroso compounds, tobacco and mycotoxins, edited by I. K. O'Neill, J. Chen, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 105 (1991) 558–563.Search in Google Scholar

79. Mirvish, S. S., A. Cardesa, L. Wallcave, and P. Shubik: Induction of lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: Effects of ascorbate, gallic acid, thiocyanate, and caffeine; J. Natl. Cancer Inst. 55 (1975) 633–636.Search in Google Scholar

80. Thompson, H. J.: Effect of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea; Carcinogenesis 12 (1991) 2175–2179.Search in Google Scholar

81. Matsumoto, M., R. Oyashu, M. L. Hopp, and T. Kitajima: Suppression of dibutylnitrosamine-induced bladder cancer carcinomas in hamsters; J. Natl. Cancer Inst. 58 (1977) 1825–1829.Search in Google Scholar

82. Wattenberg, L. W. and J. B. Coccia: Inhibition of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone carcinoge-nesis in mice by d-limonene and citrus fruit oils; Carci-nogenesis 12 (1991) 115–117.Search in Google Scholar

83. Lo, L. W. and H. F. Stich: The use of short-term tests to measure the preventive action of reducing agents on formation and activation of carcinogenic nitroso com-pounds; Mutat. Res. 57 (1978) 57–67.Search in Google Scholar

84. Teel, R. and A. Castonguay: Antimutagenic effects of polyphenolic compounds; Cancer Lett. 66 (1992) 107–113.Search in Google Scholar

85. Schüller, H. M., A. Castonguay, M. Orloff, and G. Rossignol: Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine; Cancer Res. 51 (1991) 2009–2114.Search in Google Scholar

86. Chung, F. L., M. A. Morse, K. I. Eklind, and Y. Xu: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks, edited by J. N. Diana and W. A. Pryor, Ann. NY Acad. Sci. 686 (1993) 186–202.Search in Google Scholar

87. Farinati, F., Z. Zhou, J. Bellah, C. S. Liebers, and A. J. Garro: Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung and hepatic tissue; Drug Metab. Dispos. 13 (1985) 210–214.Search in Google Scholar

88. Waddell, W. and C. Marlowe: Inhibition by alcohols of the localization of radioactive nitrosonornicotine in sites of tumor formation; Science 221 (1983) 51–52.Search in Google Scholar

89. Chung, F. L., A. Juchatz, J. Vitarius, and S. S. Hecht: Effects of dietary compounds on b-hydroxylation of N-nitrosopyrrolidine and N’-nitrosonornicotine in rat target tissues; Cancer Res. 44 (1984) 2924.Search in Google Scholar

90. Chung, F. L., A. Juchatz, J. Vitarius, B. Reiss, and S. S. Hecht: Inhibition of target tissue activation of N’-nitrosonornicotine and N-nitrosopyrrolidine by dietary components; in: N-Nitroso compounds: Occurrence, biological effects and relevance to human cancer, edited by I. K. O'Neill, R. C. von Borstel, C. T. Miller, J. Long, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 57 (1984) 797–804.Search in Google Scholar

91. Hoffmann, D., K. D. Brunnemann, J. D. Adams, and S. S. Hecht: Formation and analysis of N-nitrosamines in tobacco products and their endogenous formation in con-sumers; in: N-Nitroso compounds: Occurrence, biologi-cal effects and relationship to human cancer, edited by I. K. O'Neill, R. C. von Borstel, C. T. Miller, J. Long, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 57 (1984) 743–762.Search in Google Scholar

92. Environmental Protection Agency: Maleic hydrazide: Notification of issuances of notice of intent to suspend pesticide registration; Fed. Reg. 46 (No. 179) (1981) 45999–46000.Search in Google Scholar

93. Clapp, N. K., R. L. Tyndall, L. C. Satterfield, W. C. Klima, and N. D. Bowles: Selective sex-related modifi-cation of diethylnitrosamine-induced carcinogenesis in Balb/C mice by concomitant administration of butylated hydroxytoluene; J. Natl. Cancer Inst. 61 (1978) 177–182.Search in Google Scholar

94. Clapp, N. K., N. D. Bowles, L. C. Satterfield, and W. C. Klima: Selected protective effect of butylated hydroxy-toluene against 1,2-dimethylhydrazine carcinogenesis; J. Natl. Cancer Inst. 63 (1979) 1081–1087.Search in Google Scholar

95. Wynder, E. L., D. A. Goodman, and D. Hoffmann: Ciliatoxic components in cigarette smoke. II. Carbo-xylic acids and aldehydes; Cancer 18 (1965) 505–509.Search in Google Scholar

96. Wynder, E. L. and D. Hoffmann: Reduction of tumorigenicity of cigarette smoke. An experimental approach; J. Am. Med. Assoc. 192 (1965) 88–94.Search in Google Scholar

97. Rodgman, A., S. S. Mims, and L. C. Cook: Some com-ments on ciliary inhibition; RDM, 1964, No. 45, April 28, see www.rjrtdocs. com 500602286–2294.Search in Google Scholar

98. Dalhamn, T., M. L. Edfors, and R. Rylander: Mouth absorption of various compounds in cigarette smoke; Arch. Environ. Hlth. 16 (1968) 831–835; Retention of cigarette smoke components in human lungs; Arch. Environ. Hlth. 17 (1968) 746–748.Search in Google Scholar

99. Boutwell, R. K., H. P. Rusch, and D. K. Bosch: The action of phenols and related compounds in tumor formation; Proc. Am. Assoc. Cancer Res. (1) (1955) 6–7; Boutwell, R. K., H. P. Rusch, and B. Booth: Tumor production by phenol and related compounds; Proc. Am. Assoc. Cancer Res. 2(2) (1956) 96; Boutwell, R. K. and D. K. Bosch: The tumor-promoting action of phenols and related compounds for mouse skin; Cancer Res. 19 (1959) 413–424.Search in Google Scholar

100. Hoffmann, D. and E. L. Wynder: Die Filtration von Phenolen aus Cigarettenrauch [The filtration of phenols from cigarette smoke]; Beitr. Tabakforsch. 2 (1963) 51–66; Filtration of phenols from cigarette smoke; J. Natl. Cancer Inst. 30 (1963) 67–84.Search in Google Scholar

101. Laurene, A. H.: Adsorption of phenol by untreated Estron®; RDM, 1963, No. 5, January 8, see www.rjrtdocs. com 500612340–2343; Evaluation of triacetate B as a cigarette filter material; RDM, 1963, No. 6, January 8, see www.rjrtdocs. com 500612344–2346; A. H.: The effect of cigarette moisture content on component analysis of smoke; RDM, 1965, No. 17, February 22, see www.rjrtdocs. com 500602612–2614.Search in Google Scholar

102. Laurene, A. H., G. W. Young, and L. A. Lyerly: Phenol content in smoke as a function of the age of the ciga-rette; RDM, 1963, No. 17, February 19, see www.rjrtdocs. com 500612411–2420; Factors which affect the phenol content of cigarette smoke; RDR, 1963, No. 58, November 13, see www.rjrtdocs. com 500962130–2163.Search in Google Scholar

103. Spears, A. W.: Selective filtration of volatile phenolic compounds from cigarette smoke; Tob. Sci. 7 (1963) 76–80.Search in Google Scholar

104. Rodgman, A. and T. A. Perfetti: The chemical compo-nents of tobacco and tobacco smoke; CRC Press, Taylor and Francis Group, Boca Raton, FL, 2008.10.1201/9781420078848Search in Google Scholar

105. Hoffman, H. E. and A. C. Griffin: Action of cigarette tar and smoke on chemically induced carcinogenesis; Texas Rep. Biol. Med. 16 (1958) 333–345.Search in Google Scholar

106. Falk, H. L., P. Kotin, and S. Thompson: Inhibition of carcinogenesis. The effect of hydrocarbons and related compounds; Arch. Environ. Health 9 (1964) 169-179.Search in Google Scholar

107. Homburger, F. and A. Treger: Effects of intravenous carcinogen and tobacco condensate injections upon the incidence of lung tumors in A/He mice; in: Lung tumors in animals, edited by L. Severi, Division of Cancer Research, University of Perugia, Italy, 1965, pp. 527–536.Search in Google Scholar

108. Wynder, E. L. and D. Hoffmann: Experimental tobacco carcinogenesis; Science 162 (1968) 862–871.Search in Google Scholar

109. Hecht, S. S., R. L. Thorne, and D. Hoffmann: Studies on tumor promoters in tobacco smoke; 28th Tobacco Chemists’ Research Conference, Program Booklet and Abstracts, Vol. 28, Paper No. 42, 1974, p. 28, for presentation text, see www.rjrtdocs. com 501527005–7015.Search in Google Scholar

110. Roe, F. J. C.: The role of 3,4-benzopyrene in carcino-genesis by tobacco smoke condensate; Nature 194 (1962) 1089–1090; Role of 3,4-benzopyrene in carcinogenesis by tobacco smoke condensate; Acta Unio Internat. Contra Cancrum 19 (1963) 730.Search in Google Scholar

111. Lazar, P. H., I. Chouroulinkov, C. Libermann, and M. Guerin: Amounts of 3,4-benzpyrene (3,4-BP) in ciga-rette smoke condensates and carcinogenicity; 9th Internat. Cancer Cong., Tokyo, Japan (1966); Benzo[a]-pyrene content and carcinogenicity of cigarette smoke condensate: Results of short-term and long-term tests; J. Natl. Cancer Inst. 37 (1966) 573–579.Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo